there was an overall increase in true lumen diameter and concomitant decrease in false lumen diameter in both acute and nonacute patients at the level of the largest diameter in both the thoracic and abdominal aorta. At 5 years, 66% of acute and 81% of nonacute patients exhibited either a stable or shrinking transaortic diameter in the thoracic aorta; 52% of acute and 24% of nonacute patients experienced growth in transaortic diameter in the abdominal aorta. Five-year freedom from secondary intervention was 66% 6 8% for acute and 71% 6 9% for nonacute patients (log-rank test, P ¼ .71).
Objective: Carotid artery disease is a major cause of stroke. The in vivo structural features that connote carotid plaque rupture and symptoms remain ill-defined for a given degree of stenosis. We therefore analyzed computed tomography angiography (CTA) images of symptomatic patients enrolled in the Plaques at Risk (PARISK) study designed to determine the natural history of carotid stenosis (30%-70%) causing ipsilateral neurologic events. In each patient, the volume and patterns of calcified and noncalcified plaque components were quantitated in the symptomatic and contralateral asymptomatic carotid bifurcation.
Methods: In 44 consecutive cases, the symptomatic and contralateral asymptomatic carotid bifurcations (n ¼ 88) were subjected to quantitative ImageJ analysis and morphologic grading of plaque volume in 30 to 50 CTA axial slices/bifurcation. Total plaque, calcified and noncalcified plaque components, and percentage calcification volumes were measured. Hounsfield unit (HU) mapping was used to grade maximum calcification arc (400 HU), pattern of calcification (nodular, sheets, adventitial rim), and maximum juxtaluminal dark matter arc (100 HU) representing lipid, hemorrhage, or thrombus. For each bifurcation, North American Symptomatic Carotid Endarterectomy Trial (NASCET) and European Carotid Surgery Trial (ECST) stenosis were determined on CTA. Differences between the symptomatic and asymptomatic sides were analyzed using paired Wilcoxon rank sum.
Results: Percentage stenosis (NASCET, ESCT) was not different between the symptomatic and asymptomatic plaques (14 6 27 vs 7 6 27 [P ¼ .5] and 56 6 16 vs 52 6 16 [P ¼ .3]). There was no correlation between degree of stenosis and total plaque volume for both NASCET (r 2 ¼ 0.05; P ¼ .6) and ECST (r 2 ¼ 0.02; P ¼ .2). Total plaque volume was greater in symptomatic vs asymptomatic plaques (921 6 90 vs 801 6 102; P < .04). Juxtaluminal dark matter was more prevalent in symptomatic plaques (P < .07). Plaques with no dark matter had significantly greater percentage calcification than those with dark matter (P < .002). Overall, there was no difference in percentage calcification volume and calcium patterns between symptomatic and asymptomatic plaques.
Conclusions: In this patient-controlled study, carotid bifurcation plaque volume is greater in symptomatic than in asymptomatic patients with 30% to 70% stenosis. In contrast, degree of stenosis was not related to symptoms or correlated with plaque volume. Juxtaluminal dark matter, a surrogate for soft plaque, is more prevalent in symptomatic plaques and is associated with reduced calcification volume. However, plaque calcification volume and calcium morphologic patterns did not differ between symptomatic and asymptomatic plaques. Trials investigating the natural history of carotid disease should consider assessment of carotid plaque structural components and their transmural spatial distribution rather than relying solely on the degree of stenosis.
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VESS10. Natural History of Target Vessel Endoleaks After Fenestrated-Branched Endovascular Aortic Repair
Akhilesh K. Jain, Gustavo S. Oderich, Emanuel R. Tenorio, Jussi M. Karkkainen, Bernardo C. Mendes, Thanila A. Macedo, Terri J. Vrtiska, Peter Gloviczki. Mayo Clinic, Rochester, Minn
Objective: The objective of this study was to analyze the natural history of target vessel endoleaks detected by predismissal computed tomography angiography (CTA) after fenestrated-branched endovascular aneurysm repair (F-BEVAR) for pararenal aneurysms or thoracoabdominal aortic aneurysms (TAAAs).
Methods: We reviewed the clinical data and imaging of consecutive patients treated by F-BEVAR between 2007 and 2017. Target vessel endoleak due to insufficient attachment (type IIIC), stent fracture/tear (type IIID), or inadequate seal (type IC) was identified by predismissal CTA (Fig) . Follow-up included clinical examination, CTA, and renal-mesenteric duplex ultrasound (DUS) at 2 months, 6 months, and annually thereafter. End points were resolution or persistence of target vessel endoleak, sac enlargement (>5 mm), device migration (>10 mm), aneurysm rupture, and secondary interventions.
Results: There were 386 patients (289 male; mean age, 7567.7 years) treated by F-BEVAR for 196 pararenal aneurysms and 190 TAAAs. A total of 1350 renal-mesenteric arteries were targeted by 1027 fenestrations, 228 directional branches, and 95 scallops with a mean of 3.4 6 0.9 vessels per patient. Predismissal CTA identified any endoleak in 139 patients (36%): type II in 111 patients (29%), type III in 30 (8%), type I in 8 (2%), and indeterminate in 12 (3%). Thirty-six patients (9%) had target vessel endoleaks, including 30 type IIIC, 3 type IIID, and 3 type IC. Incidence of target vessel endoleaks was similar for fenestrations compared with directional branches (4% vs 6%; P ¼ .09). One of 36 patients died of unrelated causes, three had limited follow-up, and four underwent successful intervention before hospital dismissal because of concomitant target vessel stent compression. Of the 28 patients observed for a mean of 19 6 12 months, 20 patients (79%) had complete resolution in 6 to 8 weeks in 18 patients or within 6 months in two patients. Seven patients (25%) required redo stent placement, which resolved the endoleak in six with no complications. One patient with stable aneurysm sac was observed. Factors independently associated with target vessel endoleaks included inner aortic diameter 30 mm, higher number of targeted vessels, TAAAs, and physician-modified endografts. There was no aneurysm rupture, device migration, or conversion to open repair.
Conclusions: Target vessel endoleaks were detected in 1 of 10 patients treated by F-BEVAR, with similar incidence for fenestrations and branches. Spontaneous resolution occurred in three of four patients after a short period. Among patients with persistent endoleaks, redo stenting was usually successful and uncomplicated, and there was no aneurysm rupture, device migration, or conversion to open repair. Objective: Bowel ischemia (BI) is a rare but serious complication after abdominal aortic aneurysm (AAA) repair. We sought to identify risk factors and outcomes in patients developing BI after open aortic repair (OAR) and endovascular aneurysm repair (EVAR).
Methods: A retrospective analysis was conducted using the Vascular Quality Initiative database (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) (2016) . Univariate (Student t-test, c
2 ) and multivariate (logistic regression) analyses were used as appropriate. All models were tested using area under the curve and goodness of fit tests.
Results: We evaluated a cohort of 40,467 patients who underwent AAA repair (22.5% OAR and 87.5% EVAR). The overall incidence of postoperative BI was 2.0% (6.2% for OAR vs 0.8% for EVAR; P < .001). A decreasing trend of postoperative BI was noticed from 2003 (4.1%) to 2017 (1.6%; P < .001). Patients with BI were more likely to be female (28% vs 21%) and had a higher number of comorbidities including congestive heart failure (13% vs 11%), chronic obstructive pulmonary disease (38% vs 33%), dialysis (2% vs 1%), and American Society of Anesthesiologists classification >3 (98% vs 94%; all P < .05). In multivariate analysis, OAR was associated with fivefold increased risk for development of BI compared with EVAR (odds ratio [OR], 4.77; 95% confidence interval [CI], 3.56-6.39; P < .001). In patients undergoing OAR, history of smoking (OR, 1.59; 95% CI, 1.01-2.52), congestive heart failure (OR, 1.65; 95% CI, 1.11-2.46), transfusion (OR, 1.09; 95% CI, 1.06-1.11), ruptured aneurysm (OR, 2.68; 95% CI, 1.72-4.17), anterior exposure (OR, 1.92; 95% CI, 1.35-2.74) supraceliac clamping (OR, 1.68; 95% CI, 1.13-2.48), and reimplantation of the inferior mesenteric artery (OR, 1.68; 95% CI, (1.13-2.48) were all significant predictors of BI (all P < .05). In contrast, family history of AAA (OR, 2.47; 95% CI, 1.20-5.09), ruptured aneurysm (OR, 6.93; 95% CI, 3.03-15.82), and any concomitant procedures (OR, 4.19; 95% CI, ) were the only predictors of BI in patients undergoing EVAR. Total length of hospital stay (median days, 18 [interquartile range, 7-32] vs 10 [6-19]) and intensive care unit stay (median days, 11 [interquartile range, 4-22] vs 4.5 [2-10]) were significantly higher in patients who received surgical vs medical management for postoperative BI (both P < .001). Surgical management was also associated with nearly threefold increased risk of 30-day mortality compared with medical management of BI (OR, 2.88; 95% CI, 1.75-4.74; P < .001; Fig) . The 30-day mortality (35% vs 39%) and return to operating room (61% vs 57%) after development of BI were similar between OAR and EVAR (both P > .05).
Conclusions: Using a national vascular-specific database, OAR was associated with fivefold increased risk for development of BI compared with EVAR. Medical management of BI is associated with significant reduction in mortality and should be considered if appropriate. This study highlights some modifiable factors that can reduce BI risk, including transfusion and OAR approach (retroperitoneal). Objective: The effect that ipsilateral tunneled dialysis catheters (TDCs) has on arteriovenous fistula (AVF) maturation is unclear. We sought to define this association by comparing AVF maturation rates in patients with contralateral TDC with those in patients with ipsilateral TDC.
Methods: Review of a prospectively maintained database including all AVF creation procedures between 2009 and 2016 was performed. All patients with a TDC in place at the time of AVF creation were included in this study. Clinical and functional maturation rates were compared in patients with contralateral vs ipsilateral dialysis catheters. Categorical variables were analyzed by a two-tailed Fisher exact test. P values < .05 were considered statistically significant.
Results: There were 187 patients who underwent AVF creation with a TDC in place during the study period. There were 137 patients with a contralateral TDC and 50 with an ipsilateral TDC (Table) . A greater proportion of contralateral patients were first-time dialysis access patients at the time of index AVF creation (67% vs 48%; P ¼ .03). There was no difference in clinical (contralateral, 73%; ipsilateral, 78%; P ¼ .57) and functional (contralateral, 64%; ipsilateral, 74%) maturation rates between the two groups. The rate of TDC removal after functional AVF maturation was also not different (contralateral, 64%; ipsilateral, 72%; P ¼ .30). There was no statistically significant difference in rates of thrombosis <30 days, outflow stenosis, central stenosis, and steal syndrome.
Conclusions: There was no association between TDC sidedness and AVF maturation in our cohort. Ipsilateral TDC was also not associated with early AVF thrombosis. Planning for AVF creation should not be influenced by attempts to avoid an ipsilateral TDC. ACE, angiotensin-converting enzyme; CABG, coronary artery bypass graft; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; PCI, percutaneous coronary intervention; ROC, receiver operating characteristic.
